Investors / Media
Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult to treat diseases. Infinity Pharmaceuticals, Inc. combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity Pharmaceuticals, Inc.'s programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and phosphoinositol-3-kinase (PI3-kinase) are evidence of its innovative approach to drug discovery and development.
View all »Events
Jan 27, 2012 at 8:30 AM ET
Saridegib Update
Annual Report

Click here to view the 2010 Annual Report
View all »
Recent Releases
Sep 12, 2011
Infinity Pharmaceuticals to Present at UBS Conference
Aug 30, 2011
Infinity Pharmaceuticals to Present at Two Upcoming Conferences
Provided by eSignal.



